[Phase I-II studies on various types of interferon against malignant tumors]. 1988

Y Mitachi, and M Kambe, and M Asamura, and A Wakui

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

Y Mitachi, and M Kambe, and M Asamura, and A Wakui
June 1986, Nihon Gan Chiryo Gakkai shi,
Y Mitachi, and M Kambe, and M Asamura, and A Wakui
January 1993, Acta oncologica (Stockholm, Sweden),
Y Mitachi, and M Kambe, and M Asamura, and A Wakui
January 1991, European journal of cancer (Oxford, England : 1990),
Y Mitachi, and M Kambe, and M Asamura, and A Wakui
June 1986, Nihon Gan Chiryo Gakkai shi,
Y Mitachi, and M Kambe, and M Asamura, and A Wakui
June 1986, Nihon Gan Chiryo Gakkai shi,
Y Mitachi, and M Kambe, and M Asamura, and A Wakui
November 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
Y Mitachi, and M Kambe, and M Asamura, and A Wakui
January 1956, Acta pathologica et microbiologica Scandinavica,
Y Mitachi, and M Kambe, and M Asamura, and A Wakui
July 1967, Zentralblatt fur Gynakologie,
Y Mitachi, and M Kambe, and M Asamura, and A Wakui
January 1962, Bollettino delle malattie dell'orecchio, della gola, del naso,
Copied contents to your clipboard!